Concepedia

Publication | Open Access

Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma

57

Citations

13

References

2022

Year

Abstract

ClinicalTrials.gov Identifier: NCT03354884.

References

YearCitations

Page 1